Keywords: flamel, 1st, qtr, results, french, biopharmaceutical, company

Flamel 1st qtr results

Article | 15 May 2000

French biopharmaceutical company Flamel Technologies saw first-quarter2000 revenues leap 53.8% to $2 million, largely due to research revenues from Novo Nordisk related ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novo Nordisk

Go to company listing

Related Drugs

Humulin 70-30

Insulin

Humulin N

Humulin R

Go to drug listing